Low-dose interleukin-2 therapy is not associated with cutaneous toxicity after autologous transplantation.
López-Jiménez
J
J
De las Heras
E
E
Hilara
Y
Y
García-Laraña
J
J
Pérez-Oteyza
J
J
Bellas
C
C
Muñoz
A
A
Rocamora
A
A
Núñez
M
M
Odriozola
J
J
D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007376:Interleukin-2 / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000187:drug effects*; D014182:Transplantation, Autologous
D007376:Interleukin-2